<SEC-DOCUMENT>0001493152-21-014064.txt : 20210611
<SEC-HEADER>0001493152-21-014064.hdr.sgml : 20210611
<ACCEPTANCE-DATETIME>20210610200421
ACCESSION NUMBER:		0001493152-21-014064
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20210610
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210611
DATE AS OF CHANGE:		20210610

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ProPhase Labs, Inc.
		CENTRAL INDEX KEY:			0000868278
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				232577138
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-21617
		FILM NUMBER:		211009617

	BUSINESS ADDRESS:	
		STREET 1:		711 STEWART AVENUE
		STREET 2:		GARDEN CITY
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			11530
		BUSINESS PHONE:		(215) 345-0919

	MAIL ADDRESS:	
		STREET 1:		711 STEWART AVENUE
		STREET 2:		GARDEN CITY
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			11530

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	QUIGLEY CORP
		DATE OF NAME CHANGE:	19930328
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Washington,
D.C. 20549</B></FONT></P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>FORM
8-K</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CURRENT
REPORT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pursuant
to Section 13 or 15(d) of</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
Securities Exchange Act of 1934</B></FONT></P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Report (Date of earliest event reported): June 10, 2021</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>PROPHASE
LABS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of Company as specified in its charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>000-21617</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>23-2577138
    </B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">jurisdiction
    of incorporation)</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">File
    Number)</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    No.)</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 49%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>711
    Stewart Ave., <BR>
    Garden City, NY</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 49%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>11530</B></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of principal executive offices)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip
    Code)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company&rsquo;s
telephone number, including area code: <B>(215) 345-0919</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Company under any
of the following provisions (<I>see</I> General Instruction A.2. below):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
    &nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;
    ]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
    &nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
Registered Pursuant to Section 12(b) of the Exchange Act:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 38%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of Each Class</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
    Symbol</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 40%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Each Exchange on Which Registered</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    Stock, par value $0.0005</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRPH</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq
    Capital Market</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&sect;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&sect;240.12b-2 of this chapter).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; border-bottom: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
7.01. Regulation FD Disclosure.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 10, 2021, ProPhase Labs, Inc. issued a press release announcing the formation of two new subsidiaries, Prophase Precision Medicine,
Inc. and ProPhase Global Healthcare, Inc., along with other business developments. A copy of the press release is furnished as Exhibit
99.1 to this Current Report on Form 8-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information in this Current Report on Form 8-K, including the exhibit, is being furnished and shall not be deemed &ldquo;filed&rdquo;
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;) or otherwise subject to
the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as
amended, or the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
9.01 Financial Statements and Exhibits.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>(d)
Exhibits</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 72px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit<BR>
    Number</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10px; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
    Table</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex99-1.htm">Press Release issued by ProPhase Labs, Inc., dated June 10, 2021.</A></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ProPhase
    Labs, Inc.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="text-align: left; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Monica Brady</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Monica
    Brady</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    11, 2021</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><IMG SRC="ex99-1_001.jpg" ALT="" STYLE="height: 89px; width: 250px"></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ProPhase
Labs Diversifies with Formation of Genomics and Global Healthcare Subsidiaries</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>ProPhase
Precision Medicine, Inc. and ProPhase Global Healthcare, Inc. to Expand Opportunities in Genomics and International Testing Services</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>ProPhase
Diagnostics, Inc. Developing New Testing Capabilities through Research and Acquisition</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>CEO
Ted Karkus to Discuss New Initiatives at LD Micro Invitational XI Virtual Conference Today at 1:00 p.m. ET</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GARDEN
CITY, NY, June 10, 2021 &mdash; </B>ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, today announced
the formation of two wholly-owned subsidiaries, ProPhase Precision Medicine, Inc., which will focus on genomics testing technologies,
and ProPhase Global Healthcare, Inc., which was recently formed to seek to expand the Company&rsquo;s SARS-CoV-2 (COVID-19) testing into
other countries and to pursue additional healthcare-related initiatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ProPhase
Precision Medicine will seek to acquire existing businesses and technology, or otherwise gain access to technologies utilized to conduct
whole-genome sequencing (WGS). WGS is a comprehensive method for analyzing entire genomes, including the genes and chromosomes in DNA.
The data obtained from genomic testing can help to identify inherited disorders, predict disease risk, identify expected drug response,
and characterize genetic mutations, including those that drive cancer progression. The costs associated with whole genome sequencing
have dropped dramatically in recent years, leading to new services that can provide more detailed testing, better diagnoses, and an ability
to predict the viability of therapeutic treatments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Whole
genome sequencing is rapidly becoming a key component of the future of healthcare, with the ability to test every base in the genome,&rdquo;
said Ted Karkus, CEO of ProPhase Labs. &ldquo;ProPhase Precision Medicine was created to explore opportunities to capture market share
in the estimated multi-billion-dollar market of genomic diagnostics, offering patients the ability to understand and make informed choices
about the unique genomic variants in each of us. A genomics business within the Company may be synergistic with our existing ProPhase
Diagnostics operations if we are able to conduct these activities in conjunction with our current CLIA labs and leverage the extensive
infrastructure already built for our other lab testing services. We intend to explore available solutions that may fit our strategy.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;ProPhase
Global Healthcare was launched with the goal of developing COVID-19 testing facilities internationally and conducting additional healthcare-related
initiatives,&rdquo; continued Mr. Karkus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Karkus
added, &ldquo;With the onset of the global pandemic, testing demand has increased dramatically around the world, and we are well positioned
to leverage our knowledge and efficiencies to capture additional share in the global testing market. As we continue to seek new laboratory
acquisition targets, we are now open to opportunities that are outside the United States. This business unit is formed to pursue international
opportunities in a subsidiary that will be organized in a manner best suited to international transactions.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Consistent
with our diversification strategy, ProPhase Diagnostics is now developing antigen and antibody tests in partnerships with scientists
to broaden our COVID-19 testing beyond RT-PCR testing. Additionally, we are considering the acquisition of other laboratories in the
U.S. that may provide pathology, toxicology, blood, urine and oncology testing in order to expand beyond COVID-19 testing. Taken together,
we are highly focused on leveraging our success in the testing business to expand into other high value testing capabilities through
accretive acquisitions, licensing opportunities and R&amp;D both here and abroad.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Karkus added that, although the Company aspires to identify and consummate possible acquisition and expansion targets and opportunities,
there can be no assurance that the Company will be able to do so.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Conference
Reminder</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEO
Ted Karkus will present at the LD Micro Invitational XI virtual conference taking place June 8-10, 2021. He is scheduled to host a virtual
presentation during the event as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2021
LD Micro Invitational XI</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
Thursday, June 10, 2021</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Time:
1:00 p.m. EDT &ndash; Track 2</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Webcast:
<U>https://ldmicrojune2021.mysequire.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
live audio webcast and archive of the event presentation will be available using the webcast link above. For more information on the
LD Micro Invitational XI, or to register for the event, please visit <U>https://ldmicrojune2021.mysequire.com</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward
Looking Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
for the historical information contained herein, this document contains forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995, including statements regarding our ability to acquire companies and establish technologies
to conduct whole-genome sequencing (WGS), the perceived advantages of WGS, the estimated market for genomic diagnostics, our ability
to synergize the operations of ProPhase Precision Medicine with ProPhase Diagnostics, our ability to develop COVID-19 testing facilities
internationally and conduct additional healthcare-related initiatives, COVID-19 testing demand, and our ability to expand our testing
capabilities through accretive acquisitions, licensing opportunities and R&amp;D. Management believes that these forward-looking statements
are reasonable as and when made. However, such forward-looking statements involve known and unknown risks, uncertainties, and other factors
that may cause actual results to differ materially from those projected in the forward-looking statements. These risks and uncertainties
include but are not limited to the scale, scope and duration of the COVID-19 pandemic, consumer demand for our lab processing services,
the competitive environment, challenges relating to entering into new business lines, the failure to obtain and maintain certain regulatory
approvals, our ability to continue to ramp up our labs&rsquo; testing capacity and execute on our business plan, and the risk factors
listed from time to time in our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and any other SEC filings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
ProPhase Labs</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ProPhase
Labs (NASDAQ: PRPH) is a diversified medical science and technology company. The Company&rsquo;s subsidiary, ProPhase Diagnostics, offers
a broad array of clinical diagnostic insights and testing services at its CLIA certified laboratories. ProPhase Diagnostics serves patients
with SARS-CoV-2 (COVID-19) through both saliva and nasal swab methods. Our methodology also has the capability to identify the possibility
of mutations. Critical to COVID testing, results are provided in under 24 hours. ProPhase now also offers antigen tests for COVID-19
and polymerase chain reaction (PCR) for Influenza A and B and RSV. We also are currently developing an immunity test. ProPhase Labs researches,
develops, manufactures, distributes, markets, and sells OTC consumer healthcare products and dietary supplements, including dietary supplements
under the TK Supplements<SUP>&reg;</SUP> brand. The Company actively pursues strategic investments and acquisition opportunities for
other companies, technologies, and products. For more information, visit <U>www.ProPhaseLabs.com</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investor
Contact</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chris
Tyson</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Managing
Director</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MZ
Group - MZ North America</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">949-491-8235</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>PRPH@mzgroup.us</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>www.mzgroup.us</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-1_001.jpg
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" ": ;,# 2(  A$! Q$!_\0
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MN?M?%FFW& TIC8]G%;,-Q%.@:*177U4YKT*>(IU/A9JI)[$]%)FEK8H****
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? HHHH **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
